EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Mesotherapy With Lidocaine and Ketamine in Complex Regional Pain Syndrome Type 1: A Randomized Double‐Blind Trial

Philippe Lafuma, Laurent Magaud, Amna Abichou-Klich iD, Muriel Rabilloud, Julien Wegrzyn, Christian Baude, Pascal Rippert iD, Myriam Kaou, Julie Haesebaert, Frédéric Rongieras, Chloé Marchand, Carole Dhelens und 1 weitere

Pain Practice · 2026

DOI: 10.1111/papr.70187 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Pain Practice, 2026. Verfasst von Philippe Lafuma und 12 weiteren Autor:innen. Beteiligte Einrichtung: Hospices Civils de Lyon, Groupement Hospitalier Centre Edouard Herriot, Service de Chirurgie Orthopédique et Urgences Traumatologiques du Membre Infé…. Hauptthemen laut MEDLINE: Ketamine, Lidocaine, Anesthetics, Local, Reflex Sympathetic Dystrophy. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: French Society of Mesotherapy, the APICIL Foundation, the Health Mutual MCLR69, the Hospices Civils de Lyon Foundation, and MI Medical Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Complex regional pain syndrome type 1 (CRPS1) is a disabling pain syndrome whose treatment remains challenging. Mesotherapy is a therapeutic method involving the injection of low doses of active substances through the skin. No studies assessed mesotherapy in CRPS1 patients. The aim of this study was to evaluate the efficacy on pain relief of ketamine and lidocaine mixtures versus lidocaine alone administered by mesotherapy.

Methods

This three‐arm, randomized, double‐blind trial compared mesotherapy with lidocaine 20 mg alone or mixed with ketamine at a dose of 20 mg or 40 mg, in addition to standard treatment. The primary outcome was the difference in pain between inclusion and D56 after four mesotherapy sessions, assessed by a visual analog scale (VAS).

Results

Thirty‐one patients were randomized to receive lidocaine 20 mg ( n = 10), lidocaine 20 mg + ketamine 20 mg ( n = 11), or lidocaine 20 mg + ketamine 40 mg ( n = 10). The mean difference in VAS score between inclusion and D56 was −25.60 (95% CI: −42.81, −8.39) in the lidocaine 20 mg group, −10.13 (95% CI: −26.24, 5.99) in the lidocaine 20 mg + ketamine 20 mg group, and −19.06 (95% CI: −36.11, −2.02) in the lidocaine 20 mg + ketamine 40 mg group. There was no statistically significant difference in change of VAS score between the 3 groups ( p = 0.36). No infectious or severe adverse events occurred.

Conclusion

This study did not demonstrate the superiority of mesotherapy with ketamine and lidocaine mixtures compared to lidocaine alone in relieving pain for CRPS1 patients. Lidocaine alone or mixed with ketamine can be administered safely with a rigorous mesotherapy procedure. Trial Registration: The study was registered with ClinicalTrials.gov , number NCT04650074, and EudraCT, number 2020‐005557‐24

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetamineLidocaineAnesthetics, LocalReflex Sympathetic DystrophyMesotherapyAnalgesicsHumansDouble-Blind MethodFemaleMaleMiddle AgedAdultPain MeasurementTreatment OutcomeDrug Therapy, Combination

Stichwörter der Autor:innen

complex regional pain syndromeketaminelidocainemesotherapyrandomized trial

Substanzen

KetamineLidocaineAnesthetics, LocalAnalgesics

Autor:innen und Institutionen

  • Hospices Civils de Lyon, Groupement Hospitalier Centre Edouard Herriot, Service de Chirurgie Orthopédique et Urgences Traumatologiques du Membre Inférieur, Lyon, France.
  • Hospices Civils de Lyon, Pôle de Santé Publique, Service Recherche et Epidémiologie Cliniques, Lyon, France.
  • Hospices Civils de Lyon, Service de Biostatistique-Bioinformatique, Lyon, France.
  • Université Claude Bernard Lyon 1, UMR 5558, CNRS, Villeurbanne, France.
  • Service D'orthopédie et Traumatologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
  • Centre de la Douleur, Médipôle Lyon Villeurbanne, Villeurbanne, France.

ORCID-Profile: Amna Abichou-Klich, Pascal Rippert, Olivia Febvey-Combes

Förderung

  • French Society of Mesotherapy, the APICIL Foundation, the Health Mutual MCLR69, the Hospices Civils de Lyon Foundation, and MI Medical Innovation

Zitieren

APA

Lafuma, P., Magaud, L., Abichou-Klich, A., Rabilloud, M., Wegrzyn, J., Baude, C., Rippert, P., Kaou, M., Haesebaert, J., Rongieras, F., Marchand, C., Dhelens, C., & Febvey-Combes, O. (2026). Mesotherapy With Lidocaine and Ketamine in Complex Regional Pain Syndrome Type 1: A Randomized Double‐Blind Trial. Pain Practice. https://doi.org/10.1111/papr.70187

Vancouver

Lafuma P, Magaud L, Abichou-Klich A, Rabilloud M, Wegrzyn J, Baude C, et al. Mesotherapy With Lidocaine and Ketamine in Complex Regional Pain Syndrome Type 1: A Randomized Double‐Blind Trial. Pain Practice. 2026. doi:10.1111/papr.70187

BibTeX
@article{Lafuma2026,
  author = {Lafuma, Philippe and Magaud, Laurent and Abichou-Klich, Amna and Rabilloud, Muriel and Wegrzyn, Julien and Baude, Christian and Rippert, Pascal and Kaou, Myriam and Haesebaert, Julie and Rongieras, Frédéric and Marchand, Chloé and Dhelens, Carole and Febvey-Combes, Olivia},
  title = {Mesotherapy With Lidocaine and Ketamine in Complex Regional Pain Syndrome Type 1: A Randomized Double‐Blind Trial},
  journal = {Pain Practice},
  year = {2026},
  doi = {10.1111/papr.70187}
}
Kostenlos starten →